REVOLUTION MEDICINES INC (RVMD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RVMD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RVMD | Director | 68 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BMRN | Director, GSK PLC | 68 | ["Director, Insmed, Inc.","Director, Revolution Medicines, Inc.","extensive experience in managing large biotechnology and pharmaceutical organizations","compensation and corporate governance matters","finance and accounting","sales and marketing of both biotechnology and pharmaceutical products","held various senior leadership positions at Johnson & Johnson from 2003 to 2014","Vice President and General Manager of Wyeth Lederle Vaccines","served on the boards of GSK plc, Insmed, Inc., Revolution Medicines, Inc., Bavarian Nordic A/S, and Huntsworth PLC"] | ["Compensation Committee"] | 2026 |
| INSM | Director; Chair | 68 | ["More than 30 years of leadership in biotechnology, pharmaceuticals, and vaccines", "Extensive global marketing and infectious disease experience"] | ["Audit", "Compensation", "Chair of the Nominations and Governance Committee", "Member of the Audit Committee", "Nominations and Governance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Elizabeth McKee Anderson has served on our Board of Directors since March 2015. Ms. Anderson has served on the board of directors of GSK plc (NYSE: GSK), a pharmaceutical company, since September 2022. Ms. Anderson has served on the board of directors of BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a biotechnology company, since July 2019. Since November 2018, Ms. Anderson has served on the board of directors of Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company. Ms. Anderson previously served in various roles at Janssen Pharmaceuticals, Inc., a Johnson & Johnson company focusing on pharmaceuticals, from 2003 to 2014, most recently as Worldwide Vice President, Commercial Leader, Infectious Diseases and Vaccines, from 2012 to 2014 and Worldwide Vice President, Global Strategic Marketing and Market Access, Vaccines from 2010 to 2012 and as Worldwide Vice President, Biotechnology, Immunology and Oncology, Global Strategic Marketing from 2006 to 2010. Prior to that, Ms. Anderson served as Vice President and General Manager for Wyeth Lederle Vaccines, a division of Wyeth, a pharmaceutical company. Ms. Anderson received a B.Eng. in Engineering and Technical Management from Rutgers, The State University of New Jersey-New Brunswick and an M.B.A. in Finance from Loyola University Maryland. We believe that Ms. Anderson s extensive experience in biotechnology and pharmaceutical companies and in serving on the boards of directors of biopharmaceutical and life sciences companies provides her with the qualifications and skills necessary to serve as a member of our Board of Directors.